As sst5 receptors are expressed on tissues such as pancreatic islet cells [19], the higher levels of hyperglycemia observed with pasireotide may be a result of its higher binding affinity for sst5 compared with other somatostatin analogues. Here, SSTR5 is linked to Hyperglycemia.